Literature DB >> 2581705

Purification of human interleukin 1 from human monocyte culture supernatants and identity of thymocyte comitogenic factor, fibroblast-proliferation factor, acute-phase protein-inducing factor, and endogenous pyrogen.

K Matsushima, S K Durum, E S Kimball, J J Oppenheim.   

Abstract

Human interleukin 1 (IL-1) in lipopolysaccharide and silica-stimulated human peripheral blood monocyte culture supernatants was purified to apparent homogeneity by sequential chromatography using DEAE-Sephacel, Sephacryl S-200, CM-high-performance liquid chromatography (HPLC), and hydroxyapatite-HPLC. Analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) yielded only one band detectable by silver staining with an apparent molecular weight (MW) of 19,000 under nonreducing conditions. IL-1 activity was eluted from a single site from PAGE performed in the absence of SDS. About 4.4 micrograms of IL-1 was purified from 5.0 liters of culture supernatant of lipopolysaccharide- and silica-stimulated human peripheral blood monocytes, with 46.6% recovery of biological activity. The specific activity of the purified IL-1 was 4.3 X 10(7) U/mg protein. Amino acid composition analysis of the purified human IL-1 was similar to that previously described for murine IL-1. The purified IL-1 exhibited the biological activities previously attributed to IL-1, including thymocyte comitogenic activity, fibroblast proliferation activity, acute-phase protein (haptoglobin)-inducing activity, and endogenous pyrogen activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581705     DOI: 10.1016/0008-8749(85)90010-3

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  11 in total

Review 1.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

Review 2.  An update on human interleukin-1: from molecular biology to clinical relevance.

Authors:  C A Dinarello
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

3.  Multiple biological activities of human recombinant interleukin 1.

Authors:  C A Dinarello; J G Cannon; J W Mier; H A Bernheim; G LoPreste; D L Lynn; R N Love; A C Webb; P E Auron; R C Reuben
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

4.  Reduced IL-1 production in adolescents with mite antigen asthma in remission.

Authors:  T Noma; K Ichikawa; I Yoshizawa; K Aoki; Y Kawano; M Baba
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

5.  Antibodies to interleukin-1 raised with synthetic peptides: identification of external sites and analysis of interleukin-1 synthesis in stimulated human peripheral blood monocytes.

Authors:  R Bomford; E Abdulla; C Hughes-Jenkins; D Simpkin; J Schmidt
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

6.  Pyrogenic and haematological effects of the interferon-inducing 22K factor (interleukin 1 beta) from human leukocytes.

Authors:  J van Damme; G Opdenakker; M de Ley; H Heremans; A Billiau
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

7.  Effects of human interleukin-1 on natural killer cell activity: is fever a host defense mechanism for tumor killing?

Authors:  C A Dinarello; P Conti; J W Mier
Journal:  Yale J Biol Med       Date:  1986 Mar-Apr

8.  Purification to homogeneity and amino acid sequence analysis of two anionic species of human interleukin 1.

Authors:  P M Cameron; G A Limjuco; J Chin; L Silberstein; J A Schmidt
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

9.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

10.  Murine tumor cells metastasizing selectively in the liver: ability to produce hepatocyte-activating cytokines interleukin-1 and/or -6.

Authors:  K Takeda; N Fujii; Y Nitta; H Sakihara; K Nakayama; H Rikiishi; K Kumagai
Journal:  Jpn J Cancer Res       Date:  1991-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.